Related Experiment Videos
Fluorine-18-fluorodeoxyglucose uptake in pneumonia
L O Kapucu1, C C Meltzer, D W Townsend
1PET Facility, Department of Radiology, University of Pittsburgh Medical Center, Pennsylvania 15213-2582, USA.
Abstract:
Whole-body PET imaging with 18F-fluorodeoxyglucose (FDG) has been shown to be effective in distinguishing benign and malignant pulmonary disease. Mild elevations in FDG uptake with standardized uptake values (SUVs) less than 2.5 have been reported in benign lesions, including pneumonia. We report a case of presumed bacterial pneumonia with markedly elevated FDG uptake in a patient with a concomitant squamous cell carcinoma in the contralateral lung. SUV's were similar for both lesions (4.9 and 5.4). This case demonstrates an inflammatory etiology for false-positive FDG PET imaging in the evaluation of focal pulmonary abnormalities.
Insights
Whole-body positron emission tomography (PET) scans using 18F-fluorodeoxyglucose (FDG) can misdiagnose pneumonia as cancer. Markedly elevated FDG uptake in pneumonia can mimic malignant tumors, leading to potential false positives in lung abnormality evaluations.
Area of Science:
- Nuclear Medicine
- Oncology
- Pulmonology
Background:
- Whole-body 18F-fluorodeoxyglucose (FDG) PET imaging is a key tool for differentiating benign and malignant pulmonary lesions.
- Elevated FDG uptake, with standardized uptake values (SUVs) below 2.5, is typically associated with benign conditions like pneumonia.
- Accurate interpretation is crucial for patient management and avoiding unnecessary interventions.
Observation:
- A case study involving a patient with presumed bacterial pneumonia and a concurrent squamous cell carcinoma in the contralateral lung.
- Both the pneumonia and the squamous cell carcinoma exhibited markedly elevated FDG uptake.
- The standardized uptake values (SUVs) for both lesions were notably similar, recorded at 4.9 and 5.4.
Findings:
- Bacterial pneumonia can present with significantly high FDG uptake, similar to that of malignant lung lesions.
- This high uptake in inflammatory processes can lead to false-positive results in FDG PET imaging.
- The findings challenge the typical SUV threshold used to distinguish benign from malignant pulmonary abnormalities.
Implications:
- Inflammatory conditions, such as pneumonia, should be considered as potential causes of false-positive FDG PET findings in focal pulmonary abnormalities.
- Clinicians should exercise caution when interpreting elevated FDG uptake in the lungs, especially when clinical suspicion for infection is present.
- This case highlights the need for careful correlation with clinical and other imaging findings to avoid misdiagnosis.